As per Yahoo's financial summary 30/9/14, Biosensor has 526.86M in cash against a debt of 304.88M. its book value stands at $0.75 per share. At the current price and healthy financial sheets, the company could be a good target for taking over. It will be interesting to know what is in the mind of the managements other than buying back its own shares.

Biosensor's report for Quarter ended 30/6/14 gave NAV of US$ 0.7578 (~S$0.9)/share. At the current price of 0.69, the counter is undervalued.